KOPRAN
Back to Balance Sheet
|
KOPRAN Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹33 Cr | ₹33 Cr | ₹33 Cr | ₹34 Cr | ₹40 Cr |
What is the latest Total Non-Current Liabilities ratio of KOPRAN ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹33 Cr |
Mar2023 | ₹33 Cr |
Mar2022 | ₹33 Cr |
Mar2021 | ₹34 Cr |
Mar2020 | ₹40 Cr |
How is Total Non-Current Liabilities of KOPRAN Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹33 Cr | -0.03 | |
Mar2023 | ₹33 Cr | 1.05 | |
Mar2022 | ₹33 Cr | -1.59 | |
Mar2021 | ₹34 Cr | -16.83 | |
Mar2020 | ₹40 Cr | - |
Compare Total Non-Current Liabilities of peers of KOPRAN
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
KOPRAN | ₹1,553.0 Cr | -7.8% | 2% | 41.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹447,596.0 Cr | 0.1% | 6.6% | 60.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹144,695.0 Cr | -0.5% | 11% | 42.5% | Stock Analytics | |
CIPLA | ₹132,401.0 Cr | -1.2% | 3.4% | 32.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹109,341.0 Cr | -1.4% | -6% | 11.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹106,198.0 Cr | -5.4% | -12.8% | 63.3% | Stock Analytics |
KOPRAN Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
KOPRAN | -7.8% |
2% |
41.5% |
SENSEX | 2% |
4.5% |
25.2% |
You may also like the below Video Courses